As per the SEBI [Prohibition of Insider Trading] Regulations, 2015 and amendments thereto and as per policy on code of conduct for prevention of insider trading and fair disclosure of unpublished price sensitive information of the Company, Anlon Healthcare has informed that the trading window for dealing in the securities of the Company shall be closed for Company's Promoters & Promoter group, Directors, Key Managerial Personnel, Designated Employees, Connected/Designated Persons and their immediate relatives of respective persons aforementioned with effect from Wednesday, July 01, 2026 till the expiry of 48 hours after declaration of Unaudited Financial Results for the Quarter ended June 30, 2026. This information is being informed to Company's Promoters & Promoter group, Directors, Key Managerial Personnel, Designated Employees, Connected/Designated Persons and Immediate relatives of respective persons in accordance with code of conduct. Accordingly, all aforesaid persons are advised not to trade in the securities of the Company during the aforesaid period of closure of trading window.
The above information is a part of company’s filings submitted to BSE.
